Related Experiment Videos

Seizures with intravenous codeine phosphate

M Zolezzi1, S A Al Mohaimeed

  • 1Department of Pharmaceutical Services, Riyadh Armed Forces Hospital, Kingdom of Saudi Arabia. monizolezzi@yahoo.com

Insights

Intravenous codeine phosphate can cause seizures in children with sickle cell anemia. Clear guidelines for its administration are needed to prevent adverse reactions during acute pain management.

Area of Science:

  • Pediatric Hematology
  • Clinical Pharmacology
  • Neurology

Background:

  • Sickle cell anemia patients often require potent analgesics for pain crises.
  • Intravenous codeine phosphate is used for acute pain management.

Observation:

  • A seven-year-old boy with sickle cell anemia experienced a tonic-clonic seizure immediately after receiving intravenous codeine phosphate for pain.
  • The seizure was successfully treated with intravenous diazepam and naloxone.

Findings:

  • Codeine phosphate-induced seizures are a rare but serious adverse effect.
  • The intravenous administration route may increase the risk of seizures, particularly in vulnerable populations like children with sickle cell anemia.

Implications:

  • This case highlights the need for cautious use of intravenous codeine phosphate in children with sickle cell anemia.
  • Development of specific guidelines for parenteral codeine administration is crucial to ensure patient safety and prevent seizures.
Abstract

Related Concept Videos